ABOUT

The EHS Task Force has been set up due to the considerable success with the launching of the European Health Summit last December in 2020. This platform has been designed to drive policy in the domain of health, aside from organizing high-level annual events.
The aim is not only to create a larger healthcare network and provide visibility, but also to be able to steer the process of policy making at the European level and strengthen the link between public and private partnership through the involvement of cross-sectorial stakeholders.

PROGRAMME OF 2021

30 March 2021

WORKING GROUP 1 (CLOSED MEETING): Pandemics and vaccines, HERA Incubator

23 April 2021 – 10:00 AM CET

EHS TASK FORCE PUBLIC DEBATE: PANDEMICS AND VACCINES, HERA INCUBATOR

Pierre Delsaux
DG SANTÉ, European Commission
Deputy Director General

Mehreen Khan
Financial Times Brussels Correspondent

Michel Goldman
I3h Institute, ULB
President

Maria Carvalho
Member of the European Parliament

Luc Debruyne
Strategy Advisor to CEO, CEPI
Former CEO, GSK Vaccines

Heike Galbraith
Pfizer
Global Director rare diseases and vaccines

Sam Proesmans
Advisor to the Belgian Prime Minister

Elena Bonfiglioli
Microsoft
Regional business leader health and life sciences EMEA

What is Europe’s strategy in combating COVID-19 strains?
The first public event of the EHS Task Force will debate the Commission’s work on emergency preparedness and the EU’s capacity to swiftly secure access to the necessary vaccines, whenever needed. Join our discussion on HERA (European Health Emergency Preparedness and Response Authority) Incubator.

May 2021

WORKING GROUP 2 (CLOSED MEETING): EUROPEAN HEALTH DATA SPACE (USE OF RWD data, validating use of secondary data)

May 2021

EHS Task Force PUBLIC DEBATE – EUROPEAN HEALTH DATA SPACE

24 May 2021

Orientation Session for Working Group 3 (CLOSED MEETING)- INNOVATIVE MEDICINE, RARE DISEASES, ADVANCED THERAPIES

8 June 2021

Working group 3 (CLOSED MEETING): Innovative medicine, rare diseases, advanced therapies

29 June 2021

EHS Task Force PUBLIC debate: Innovative medicine, rare diseases, advanced therapies

September 2021

Working Group 4 (CLOSED MEETING): HERA STATUS

October 2021

EHS Task Force PUBLIC debate: HERA STATUS

Have a question? Contact our team!

Felicia Balan

PROJECT MANAGER

+32 (0) 2 645 3 484

Dafne Forni

PARTNERSHIP MANAGER

+32 (0) 2 645 3 489

Partners

Untitled design-102
Untitled design-103